737 related articles for article (PubMed ID: 32682859)
1. First trimester preeclampsia screening and prediction.
Chaemsaithong P; Sahota DS; Poon LC
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1071-S1097.e2. PubMed ID: 32682859
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
[TBL] [Abstract][Full Text] [Related]
3. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
4. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
[TBL] [Abstract][Full Text] [Related]
5. Two-stage screening for preterm preeclampsia at 11-13 weeks' gestation.
Wright A; Wright D; Syngelaki A; Georgantis A; Nicolaides KH
Am J Obstet Gynecol; 2019 Feb; 220(2):197.e1-197.e11. PubMed ID: 30414394
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of second trimester prediction of preterm preeclampsia by three different screening algorithms.
Al-Amin A; Rolnik DL; Black C; White A; Stolarek C; Brennecke S; da Silva Costa F
Aust N Z J Obstet Gynaecol; 2018 Apr; 58(2):192-196. PubMed ID: 28850663
[TBL] [Abstract][Full Text] [Related]
7. Prediction of preeclampsia in asymptomatic women.
Lee NMW; Chaemsaithong P; Poon LC
Best Pract Res Clin Obstet Gynaecol; 2024 Feb; 92():102436. PubMed ID: 38056380
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening.
Moungmaithong S; Kwan AH; Tse AW; Wong NK; Lam MS; Wang J; Poon LC; Sahota DS
PLoS One; 2023; 18(7):e0288289. PubMed ID: 37428792
[TBL] [Abstract][Full Text] [Related]
9. Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain.
Cuenca-Gómez D; de Paco Matallana C; Rolle V; Valiño N; Revello R; Adiego B; Mendoza M; Molina FS; Carrillo MP; Delgado JL; Wright A; Santacruz B; Gil MM
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):522-530. PubMed ID: 37099759
[TBL] [Abstract][Full Text] [Related]
10. First-trimester pre-eclampsia biomarker profiles in Asian population: multicenter cohort study.
Chaemsaithong P; Sahota D; Pooh RK; Zheng M; Ma R; Chaiyasit N; Koide K; Shaw SW; Seshadri S; Choolani M; Panchalee T; Yapan P; Sim WS; Sekizawa A; Hu Y; Shiozaki A; Saito S; Leung TY; Poon LC
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):206-214. PubMed ID: 31671479
[TBL] [Abstract][Full Text] [Related]
11. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations.
O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; de Alvarado M; Carbone IF; Dutemeyer V; Fiolna M; Frick A; Karagiotis N; Mastrodima S; de Paco Matallana C; Papaioannou G; Pazos A; Plasencia W; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):756-760. PubMed ID: 28295782
[TBL] [Abstract][Full Text] [Related]
12. Prospective Validation of First-Trimester Screening for Preterm Preeclampsia in Nulliparous Women (PREDICTION Study).
Guerby P; Audibert F; Johnson JA; Okun N; Giguère Y; Forest JC; Chaillet N; Mâsse B; Wright D; Ghesquiere L; Bujold E
Hypertension; 2024 Jul; 81(7):1574-1582. PubMed ID: 38708601
[TBL] [Abstract][Full Text] [Related]
13. ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm.
Poon LC; Rolnik DL; Tan MY; Delgado JL; Tsokaki T; Akolekar R; Singh M; Andrade W; Efeturk T; Jani JC; Plasencia W; Papaioannou G; Blazquez AR; Carbone IF; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):738-742. PubMed ID: 29380918
[TBL] [Abstract][Full Text] [Related]
14. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
[TBL] [Abstract][Full Text] [Related]
15. The need for implementation of first trimester screening for preeclampsia and fetal growth restriction in low resource settings.
Lakshmy S; Ziyaulla T; Rose N
J Matern Fetal Neonatal Med; 2021 Dec; 34(24):4082-4089. PubMed ID: 31900014
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of screening performance of first-trimester competing-risks prediction model for small-for-gestational age in Asian population.
Nguyen-Hoang L; Papastefanou I; Sahota DS; Pooh RK; Zheng M; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Yapan P; Sim WS; Poon LC;
Ultrasound Obstet Gynecol; 2024 Mar; 63(3):331-341. PubMed ID: 37552550
[TBL] [Abstract][Full Text] [Related]
17. Predictive performance of the competing risk model in screening for preeclampsia.
Wright D; Tan MY; O'Gorman N; Poon LC; Syngelaki A; Wright A; Nicolaides KH
Am J Obstet Gynecol; 2019 Feb; 220(2):199.e1-199.e13. PubMed ID: 30447210
[TBL] [Abstract][Full Text] [Related]
18. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
[TBL] [Abstract][Full Text] [Related]
20. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
Shen L; Martinez-Portilla RJ; Rolnik DL; Poon LC
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):546-552. PubMed ID: 33998099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
